BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,339,000 | +79.0% | 1,439,825 | +116.1% | 0.02% | +87.5% |
| Q2 2023 | $30,353,000 | +28.1% | 666,230 | +14.1% | 0.01% | +14.3% |
| Q1 2023 | $23,691,000 | -26.8% | 584,115 | -8.0% | 0.01% | -22.2% |
| Q4 2022 | $32,345,000 | +12.3% | 634,613 | +18.6% | 0.01% | 0.0% |
| Q3 2022 | $28,812,000 | -13.2% | 534,931 | +3.6% | 0.01% | -10.0% |
| Q2 2022 | $33,175,000 | -62.8% | 516,500 | -55.1% | 0.01% | -54.5% |
| Q1 2022 | $89,143,000 | -21.3% | 1,149,658 | -12.9% | 0.02% | -15.4% |
| Q4 2021 | $113,254,000 | +31.1% | 1,319,353 | +22.9% | 0.03% | +13.0% |
| Q3 2021 | $86,357,000 | +49.6% | 1,073,682 | +49.7% | 0.02% | +53.3% |
| Q2 2021 | $57,743,000 | +14.4% | 717,330 | +19.8% | 0.02% | 0.0% |
| Q1 2021 | $50,488,000 | +3.2% | 598,630 | -1.8% | 0.02% | +7.1% |
| Q4 2020 | $48,939,000 | +17.6% | 609,910 | +17.8% | 0.01% | -6.7% |
| Q3 2020 | $41,630,000 | -13.1% | 517,680 | -7.0% | 0.02% | -21.1% |
| Q2 2020 | $47,904,000 | +24.7% | 556,381 | +17.5% | 0.02% | 0.0% |
| Q1 2020 | $38,430,000 | -44.2% | 473,343 | -42.6% | 0.02% | -24.0% |
| Q4 2019 | $68,915,000 | -46.2% | 824,164 | -43.8% | 0.02% | -51.0% |
| Q3 2019 | $128,162,000 | +30.4% | 1,465,217 | +22.1% | 0.05% | +30.8% |
| Q2 2019 | $98,256,000 | -6.6% | 1,199,716 | -7.3% | 0.04% | -13.3% |
| Q1 2019 | $105,206,000 | +24.3% | 1,293,880 | +0.6% | 0.04% | +9.8% |
| Q4 2018 | $84,663,000 | -13.4% | 1,286,323 | +2.0% | 0.04% | 0.0% |
| Q3 2018 | $97,772,000 | +20.4% | 1,261,013 | +14.7% | 0.04% | +13.9% |
| Q2 2018 | $81,181,000 | +87.3% | 1,099,388 | +65.0% | 0.04% | +89.5% |
| Q1 2018 | $43,346,000 | -20.6% | 666,436 | -21.1% | 0.02% | -20.8% |
| Q4 2017 | $54,601,000 | -16.8% | 844,691 | -19.2% | 0.02% | -25.0% |
| Q3 2017 | $65,599,000 | -1.2% | 1,045,407 | -4.7% | 0.03% | -8.6% |
| Q2 2017 | $66,402,000 | +15.7% | 1,096,840 | -0.9% | 0.04% | +12.9% |
| Q1 2017 | $57,387,000 | -18.9% | 1,106,564 | -30.6% | 0.03% | -18.4% |
| Q4 2016 | $70,719,000 | +8.2% | 1,594,945 | +16.2% | 0.04% | +2.7% |
| Q3 2016 | $65,337,000 | +53.2% | 1,372,593 | +45.5% | 0.04% | +48.0% |
| Q2 2016 | $42,646,000 | +38.9% | 943,079 | +26.2% | 0.02% | +31.6% |
| Q1 2016 | $30,711,000 | +72.8% | 747,553 | +60.5% | 0.02% | +58.3% |
| Q4 2015 | $17,773,000 | -1.6% | 465,851 | -15.3% | 0.01% | -14.3% |
| Q3 2015 | $18,069,000 | -69.2% | 550,010 | -34.4% | 0.01% | -65.9% |
| Q2 2015 | $58,673,000 | +47.7% | 839,013 | +44.7% | 0.04% | +46.4% |
| Q1 2015 | $39,725,000 | -55.5% | 579,939 | -52.4% | 0.03% | -51.7% |
| Q4 2014 | $89,331,000 | +21.5% | 1,218,858 | +19.0% | 0.06% | +16.0% |
| Q3 2014 | $73,510,000 | +29.6% | 1,024,238 | +30.6% | 0.05% | +31.6% |
| Q2 2014 | $56,721,000 | +28.2% | 784,530 | +30.5% | 0.04% | +18.8% |
| Q1 2014 | $44,239,000 | -25.4% | 601,240 | -29.4% | 0.03% | -23.8% |
| Q4 2013 | $59,271,000 | -15.4% | 852,188 | -20.1% | 0.04% | -22.2% |
| Q3 2013 | $70,023,000 | +9.9% | 1,065,967 | +15.9% | 0.05% | 0.0% |
| Q2 2013 | $63,731,000 | – | 920,037 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |